Capital-India-Finance (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance … | |||||||||||||||
BSE surveillance requested clarifications from Solara Active Pharma Sciences, Bombay Burmah Trading Corporation, and Capital India Finance regarding significant increase in trading volumes. All companies confirmed compliance with disclosure requirements and stated no price-sensitive information was withheld.
| |||||||||||||||
New debt securities worth Rs. 50 crore issued by Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate. | |||||||||||||||
New debt securities worth Rs. 50 crore issued by Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate.
| |||||||||||||||
New debt securities of Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate and 3-year tenure. | |||||||||||||||
New debt securities of Capital India Finance Limited listed on BSE Debt segment with 9.55% interest rate and 3-year tenure.
| |||||||||||||||
BSE announces listing of new debt securities worth Rs. 50 crores by Capital India Finance Limited on private placement basis. | |||||||||||||||
BSE announces listing of new debt securities worth Rs. 50 crores by Capital India Finance Limited on private placement basis.
| |||||||||||||||